| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCRESAHA.108.186742 |
| P698 | PubMed publication ID | 18948617 |
| P2093 | author name string | Muhammad Ashraf | |
| Shujia Jiang | |||
| Husnain Kh Haider | |||
| Niagara M Idris | |||
| P433 | issue | 11 | |
| P921 | main subject | overexpression | Q61643320 |
| mesenchymal stem cell | Q1922379 | ||
| bone marrow | Q546523 | ||
| P304 | page(s) | 1300-1308 | |
| P577 | publication date | 2008-10-23 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. | |
| P478 | volume | 103 |
| Q35621019 | A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome |
| Q92861489 | A brief review of cytotoxicity of nanoparticles on mesenchymal stem cells in regenerative medicine |
| Q33768499 | A brief review: adipose-derived stem cells and their therapeutic potential in cardiovascular diseases |
| Q37801128 | A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation |
| Q36346991 | Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. |
| Q91666691 | Advancement in Stem Cell Therapy for Ischemic Myocardial Cell: A Systematic Review |
| Q34271025 | An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile |
| Q38201302 | An update of human mesenchymal stem cell biology and their clinical uses. |
| Q36280879 | Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration. |
| Q37714724 | Assessed and Emerging Biomarkers in Stroke and Training-Mediated Stroke Recovery: State of the Art. |
| Q37355601 | Atorvastatin treatment of rats with ischemia-reperfusion injury improves adipose-derived mesenchymal stem cell migration and survival via the SDF-1α/CXCR-4 axis |
| Q37837891 | Autologous cell therapy for cardiac repair. |
| Q64239467 | Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction |
| Q59124191 | Biomimetic Platforms for Tissue Engineering |
| Q30472457 | Bone marrow cell recruitment mediated by inducible nitric oxide synthase/stromal cell-derived factor-1alpha signaling repairs the acoustically damaged cochlear blood-labyrinth barrier |
| Q42517934 | Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. |
| Q33745166 | Bone marrow-derived cells contribute to fibrosis in the chronically failing heart |
| Q39017865 | Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells |
| Q37371934 | Cardiac cell repair therapy: a clinical perspective |
| Q37986552 | Cardiac cell therapy: boosting mesenchymal stem cells effects |
| Q55325535 | Cardiac cell-derived exosomes: changing face of regenerative biology. |
| Q34856239 | Cardiac progenitor cell commitment is inhibited by nuclear Akt expression |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q40529277 | Cardiac stem cell genetic engineering using the alphaMHC promoter. |
| Q26765916 | Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration |
| Q34596348 | Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms |
| Q39410733 | Cellular mechanisms underlying cardiac engraftment of stem cells. |
| Q35216154 | Circulating stem cell vary with NYHA stage in heart failure patients |
| Q37496432 | Combinatorial biomatrix/cell-based therapies for restoration of host tissue architecture and function |
| Q34977853 | Composite scaffold provides a cell delivery platform for cardiovascular repair |
| Q38314852 | Concise Review: Mesenchymal Stem Cells Ameliorate Tissue Injury via Secretion of Tumor Necrosis Factor-α Stimulated Protein/Gene 6. |
| Q33975631 | Concise review: new frontiers in microRNA-based tissue regeneration |
| Q30834431 | Core Transcription Factors, MicroRNAs, and Small Molecules Drive Transdifferentiation of Human Fibroblasts Towards The Cardiac Cell Lineage |
| Q55435775 | Current Progress in the Rejuvenation of Aging Stem/Progenitor Cells for Improving the Therapeutic Effectiveness of Myocardial Repair. |
| Q47875896 | Daunorubicin Down-Regulates the Expression of Stem Cell Markers and Factors Involved in Stem Cell Migration and Homing in Rat Heart in Subchronic but not Acute Cardiomyopathy |
| Q34271595 | De novo myocardial regeneration: advances and pitfalls |
| Q30480280 | Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1. |
| Q37067760 | Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation |
| Q54531288 | Effect of the calcium sensing receptor on rat bone marrow-derived mesenchymal stem cell proliferation through the ERK1/2 pathway. |
| Q35120149 | Effects of cytokines and chemokines on migration of mesenchymal stem cells following spinal cord injury |
| Q34239856 | Empowering adult stem cells for myocardial regeneration |
| Q50035033 | Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models |
| Q35060703 | Engineering cells with intracellular agent-loaded microparticles to control cell phenotype |
| Q55255305 | Enhanced Homing Technique of Mesenchymal Stem Cells Using Iron Oxide Nanoparticles by Magnetic Attraction in Olfactory-Injured Mouse Models. |
| Q98245653 | Enhancing myocardial repair with CardioClusters |
| Q34215785 | Excitation-contraction coupling in ventricular myocytes is enhanced by paracrine signaling from mesenchymal stem cells |
| Q35387888 | Exendin-4 enhances the migration of adipose-derived stem cells to neonatal rat ventricular cardiomyocyte-derived conditioned medium via the phosphoinositide 3-kinase/Akt-stromal cell-derived factor-1α/CXC chemokine receptor 4 pathway |
| Q48692636 | Exogenous connexin43-expressing autologous skeletal myoblasts ameliorate mechanical function and electrical activity of the rabbit heart after experimental infarction |
| Q49404531 | Exosome-like silica nanoparticles: a novel ultrasound contrast agent for stem cell imaging |
| Q33722247 | Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D |
| Q27009438 | Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases? |
| Q39498749 | GSK3β regulates physiological migration of stem/progenitor cells via cytoskeletal rearrangement |
| Q24632135 | Gene therapy for ischemic heart disease |
| Q47863866 | Generation and characterization of transgenic mouse mesenchymal stem cell lines expressing hIGF-1 or hG-CSF. |
| Q99712184 | Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine |
| Q34298871 | Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy |
| Q47405412 | Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell |
| Q34389737 | Global knockdown of microRNAs affects the expression of growth factors and cytokines in human adipose-derived mesenchymal stem cells |
| Q50066251 | Harnessing Epicardial Progenitor Cells and Their Derivatives for Rescue and Repair of Cardiac Tissue After Myocardial Infarction |
| Q35804026 | Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease |
| Q37276182 | Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen |
| Q37788681 | Homing Pathways of Mesenchymal Stromal Cells (MSCs) and Their Role in Clinical Applications |
| Q34920315 | Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1. |
| Q42317786 | Human mesenchymal stem cell homing induced by SKOV3 cells |
| Q37245118 | Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart |
| Q34038093 | Hyperthermia differently affects connexin43 expression and gap junction permeability in skeletal myoblasts and HeLa cells. |
| Q41815870 | IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI. |
| Q90683636 | IGF-1C domain-modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI |
| Q47093464 | Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel |
| Q37580099 | In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment |
| Q35078827 | In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability |
| Q91878243 | In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair |
| Q42604737 | Induced bone marrow mesenchymal stem cells improve cardiac performance of infarcted rat hearts |
| Q43088336 | Influencing the secretion of myogenic factors from mesenchymal stem cells. |
| Q33746634 | Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling |
| Q88106861 | Insulin-like growth factor 1 treatment of MSCs attenuates inflammation and cardiac dysfunction following MI |
| Q33908836 | Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4. |
| Q35601392 | Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair |
| Q83333021 | Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice |
| Q38648551 | Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors |
| Q24648959 | Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2 |
| Q38719569 | Lentiviral vector-mediated co-overexpression of VEGF and Bcl-2 improves mesenchymal stem cell survival and enhances paracrine effects in vitro |
| Q36089888 | Lentiviral-mediated growth-associated protein-43 modification of bone marrow mesenchymal stem cells improves traumatic optic neuropathy in rats |
| Q33985922 | Local activation of cardiac stem cells for post-myocardial infarction cardiac repair |
| Q33911038 | Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction |
| Q35030040 | Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. |
| Q36630908 | Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplant |
| Q88884604 | Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges |
| Q22252511 | Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury |
| Q33765470 | Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration |
| Q26770191 | Mesenchymal stem cells and immunomodulation: current status and future prospects |
| Q38816740 | Mesenchymal stem cells and vascular regeneration. |
| Q34676808 | Mesenchymal stem cells at the intersection of cell and gene therapy |
| Q36593007 | Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling |
| Q92615294 | Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application |
| Q64251805 | Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery |
| Q52585184 | Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications. |
| Q35866749 | MicroRNA-143 is a critical regulator of cell cycle activity in stem cells with co-overexpression of Akt and angiopoietin-1 via transcriptional regulation of Erk5/cyclin D1 signaling |
| Q38829467 | Microenvironmental Interaction Between Hypoxia and Endothelial Cells Controls the Migration Ability of Placenta-Derived Mesenchymal Stem Cells via α4 Integrin and Rho Signaling |
| Q38066135 | Migration of resident cardiac stem cells in myocardial infarction |
| Q92523675 | Mircrining the injured heart with stem cell-derived exosomes: an emerging strategy of cell-free therapy |
| Q36550793 | More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair |
| Q36908289 | Myocardial AKT: the omnipresent nexus |
| Q38045804 | Myocardial regeneration of the failing heart |
| Q36820684 | Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles |
| Q36176127 | Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway |
| Q53269695 | Neural differentiation of mesenchymal stem cells influences their chemotactic responses to stromal cell-derived factor-1α. |
| Q50594471 | Non-hypoxic stabilization of HIF-Iα during coordinated interaction between Akt and angiopoietin-1 enhances endothelial commitment of bone marrow stem cells. |
| Q36369145 | Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction |
| Q46467341 | Nox2 and Nox4 regulate self-renewal of murine induced-pluripotent stem cells |
| Q35906492 | Optical mapping of cryoinjured rat myocardium grafted with mesenchymal stem cells |
| Q93069246 | Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction |
| Q37786701 | Optimizing stem cell function for the treatment of ischemic heart disease |
| Q38982831 | Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology |
| Q41052065 | Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair |
| Q27304850 | Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts |
| Q34426187 | Paracrine factors released by GATA-4 overexpressed mesenchymal stem cells increase angiogenesis and cell survival |
| Q37788221 | Perivascular cells as mesenchymal stem cells |
| Q35902924 | Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) enhances engraftment and angiogenesis of mesenchymal stem cells in diabetic hindlimb ischemia |
| Q38682533 | Perspective: Cooperation of Nanog, NF-κΒ, and CXCR4 in a regulatory network for directed migration of cancer stem cells |
| Q37706602 | Potential application of adipose-derived stem cells and their secretory factors to skin: discussion from both clinical and industrial viewpoints |
| Q37766195 | Preconditioning and stem cell survival |
| Q44970917 | Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice |
| Q55564081 | Preconditioning in regenerative medicine. |
| Q34276744 | Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells |
| Q36108608 | Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope? |
| Q35755594 | Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture |
| Q39063811 | RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors |
| Q47197395 | Real-time tracking of adipose tissue-derived stem cells with injectable scaffolds in the infarcted heart |
| Q36497191 | Regenerating new heart with stem cells |
| Q92713417 | Regulation and Directing Stem Cell Fate by Tissue Engineering Functional Microenvironments: Scaffold Physical and Chemical Cues |
| Q44596939 | Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. |
| Q34562890 | Retracted: Rehmannia Glutinosa Extract Activates Endothelial Progenitor Cells in a Rat Model of Myocardial Infarction through a SDF-1 α/CXCR4 Cascade |
| Q35140094 | Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors |
| Q33753657 | Review article: current status of myocardial regeneration: new cell sources and new strategies |
| Q89038316 | Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy |
| Q50929234 | SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization. |
| Q38136243 | Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology. |
| Q33730201 | Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. |
| Q50456025 | Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction. |
| Q30273656 | Sonic Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-1/PKC pathway |
| Q34999517 | Sonic hedgehog mediates the proliferation and recruitment of transformed mesenchymal stem cells to the stomach |
| Q57463397 | Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury |
| Q28069300 | Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? |
| Q35125820 | Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. |
| Q38997197 | Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy |
| Q36599286 | Stem cell recruitment after injury: lessons for regenerative medicine |
| Q38098219 | Stem cell stimulation of endogenous myocyte regeneration |
| Q37544884 | Stem cell therapy for cardiac repair: benefits and barriers |
| Q36836349 | Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology |
| Q33348580 | Stem cell therapy: pieces of the puzzle |
| Q36176740 | Stem cells in thoracic aortic aneurysms and dissections: potential contributors to aortic repair |
| Q46896586 | Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS). |
| Q38202410 | Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium. |
| Q53258151 | Sustained IGF-1 Secretion by Adipose-Derived Stem Cells Improves Infarcted Heart Function. |
| Q52724942 | Sustained Release of Endothelial Progenitor Cell-Derived Extracellular Vesicles from Shear-Thinning Hydrogels Improves Angiogenesis and Promotes Function after Myocardial Infarction. |
| Q46074966 | Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation |
| Q45354313 | Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair |
| Q27004398 | The Regenerative Role of the Fetal and Adult Stem Cell Secretome |
| Q26778686 | The Role of Chemokines in Fibrotic Wound Healing |
| Q60908823 | The Winding Road of Cardiac Regeneration-Stem Cell Omics in the Spotlight |
| Q39152849 | The interactions and essential effects of intrinsic insulin-like growth factor-I on Leishmania (Leishmania) major growth within macrophages. |
| Q33705144 | The road ahead: working towards effective clinical translation of myocardial gene therapies |
| Q37741029 | The role of sonic hedgehog reemergence during gastric cancer |
| Q36740266 | The use of scaffold-free cell sheet technique to refine mesenchymal stromal cell-based therapy for heart failure. |
| Q30415766 | Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells. |
| Q33840741 | Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury |
| Q26774565 | Translational research of adult stem cell therapy |
| Q34599586 | Ultrasound-mediated stimulation of microbubbles after acute myocardial infarction and reperfusion ameliorates left-ventricular remodelling in mice via improvement of borderzone vascularization |
| Q35114758 | VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart |
| Q36167608 | miRNA control of tissue repair and regeneration |
| Q31039862 | microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. |
Search more.